Joshua M. Lang - Concepedia

Author

Joshua M. Lang

University of Wisconsin Carbone Cancer Center ORCID

Also Known As

Ifedayo Kuye, J LANG, J. Lang, J. M. Lang, J.M. Lang, Jiaojiao Lang, Joshua Lang, Joshua M Lang, Joshua M. Lang, Joshua Michael Lang

384

Publications

8.3K

Citations

H-Index

128

Concepts

All Affiliations

University of Wisconsin Carbone Cancer Center University of Wisconsin–Madison University of California, San Francisco Memorial Sloan Kettering Cancer Center UCSF Helen Diller Family Comprehensive Cancer Center

About

Joshua M. Lang is an author at University of Wisconsin Carbone Cancer Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	39	4.3K
2	Engineering	7	7	266
3	Health Sciences	6	6	295
4	Natural Sciences	1	1	143
5	Nursing	1	1	137

Joshua M. Lang

Publications

Citations

H-Index

Page 1

	Year	Citations
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2019	1.5K
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021 Edward M. Schaeffer, Sandy Srinivas, Emmanuel S. Antonarakis, Journal of the National Comprehensive Cancer Network	2021	522
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2023	509
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial Aditya Bardia, Wells A. Messersmith, Ebenezer A. Kio, Annals of Oncology	2021	349
The DNA methylation landscape of advanced prostate cancer Shuang G. Zhao, William S. Chen, Haolong Li, Nature Genetics ChromatinDna Methylation LandscapeUrologyMedicineEpigenetic Change	2020	332
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma Jonathan E. Rosenberg, Srikala S. Sridhar, Jingsong Zhang, Journal of Clinical Oncology	2020	311
Prostate Cancer, Version 3.2024 Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementNccn Guidelines InsightsGynecology OncologyOncology	2024	222
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, PubMed Preclinical TherapeuticsNccn Guidelines® InsightsUrologySurgical OncologyCancer Epidemiology	2022	168
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance Manish Kohli, Yeung Ho, David W. Hillman, Clinical Cancer Research	2017	159
Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration Yvona Ward, Ross Lake, Farhoud Faraji, Cell Reports	2018	153

Page 1